Larvol Delta - Efficacy-and-Safety-of-MSCNTF-NurOwn-in-Participants-With-Early-Symptomatic-ALS-and-Moderate-Disease-Presentation-in-ALS-ENDURANCE-STUDY

NurOwn (debamestrocel) - BrainStorm Cell Therap

http://clinicaltrials.gov/ct2/show/NCT06973629

May 15, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next